Bausch Health agrees to pay $45 mln to settle U.S. charges of misleading disclosures
WASHINGTON, July 31 (Reuters) - Canada-based Bausch Health Companies Inc has agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in Securities and Exchange Commission filings and earnings presentations, the SEC said on Friday.
Three former executives, including the chief executive officer of the company, formerly Valeant Pharmaceuticals, also agreed to pay penalties to settle charges against them, the SEC said. (Reporting by Tim Ahmann; Writing by Mohammad Zargham;) ((firstname.lastname@example.org;)) Keywords: BAUSCH HEALTH USA/SETTLEMENT (URGENT)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In This StoryBHC
Latest Markets Videos
- Tesla removed from S&P 500 ESG index on autopilot, discrimination concerns
- US STOCKS-Wall Street ends sharply lower as Target and growth stocks sink
- Powell says Fed to 'keep pushing' rates higher until clear inflation is falling
- Fed could cut rates in 2023, 2024 once inflation under control -Bullard